Neuraminidases 3 and 4 regulate neuronal function by catabolizing brain gangliosides

Neuraminidases 3 and 4 regulate neuronal function by catabolizing brain gangliosides

Sialylated glycolipids, gangliosides play an essential role in the central nervous system regulating recognition and signaling in neurons. Metabolic blocks in processing and catabolism of gangliosides result in development of severe neurological disorders, gangliosidoses manifesting with neurodegene...

書目詳細資料
Main Authors:	Pan, X, De Britto Pará De Aragão, C, Velasco-Martin, J, Priestman, D, Wu, H, Takahashi, K, Yamaguchi, K, Sturiale, L, Garozzo, D, Platt, F, Lamarche-Vane, N, Morales, C, Miyagi, T, Pshezhetsky, A
格式:	Journal article
出版:	Federation of American Society of Experimental Biology (FASEB) 2017

相似書籍

Combined deficiencies of endosomal ganglioside neuraminidases 3 and 4 in mice cause lysosomal GM3 gangliosidosis
由: Pshezhetsky, A, et al.
出版: (2017)

Combined deficiencies of endosomal ganglioside neuraminidases 3 and 4 in mice cause lysosomal GM3 gangliosidosis
由: Pshezhetsky, A, et al.
出版: (2017)

Altered expression of ganglioside metabolizing enzymes results in GM3 ganglioside accumulation in cerebellar cells of a mouse model of juvenile neuronal ceroid lipofuscinosis
由: Somogyi, A, et al.
出版: (2018)

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
由: Huebecker, M, et al.
出版: (2019)

An iPSC model of hereditary sensory neuropathy-1 reveals L-serine-responsive deficits in neuronal ganglioside composition and axoglial interactions
由: Clark, A, et al.
出版: (2021)

Ganglioside antibodies and neuropathies.
由: Rinaldi, S, et al.
出版: (2008)

Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis
由: Harlalka, G, et al.
出版: (2013)

GM1 ganglioside-independent intoxication by Cholera toxin
由: Cervin, J, et al.
出版: (2018)

Glycosphingolipid depletion in PC12 cells using iminosugars protects neuronal membranes from anti-ganglioside antibody mediated injury.
由: Townson, K, et al.
出版: (2008)

N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours.
由: Ranes, M, et al.
出版: (2001)

N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.
由: Baek, R, et al.
出版: (2008)

N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal sandhoff diseased mice
由: Baek, R, et al.
出版: (2004)

Substrate reduction therapy reduces brain ganglioside GM2 in neonatal Sandhoff disease mice
由: Baek, R, et al.
出版: (2005)

Brain pathology in mucopolysaccharidoses (MPS) patients with neurological forms
由: Viana, GM, et al.
出版: (2020)

Brain Pathology in Mucopolysaccharidoses (MPS) Patients with Neurological Forms
由: Viana, GM, et al.
出版: (2020)

Glucosamine amends CNS pathology in mucopolysaccharidosis IIIC mouse expressing misfolded HGSNAT
由: Pan, X, et al.
出版: (2022)

N-butyldeoxygalactonojirimycin reduces postnatal cerebellar ganglioside content in a mouse model of GM1 gangliosidosis
由: Kasperzyk, J, et al.
出版: (2004)

Dexamethasone: chondroprotective corticosteroid or catabolic killer?
由: Black, Robert Xavier, et al.
出版: (2020)

Studying catabolism of protein ADP-Ribosylation
由: Palazzo, L, et al.
出版: (2017)

Parathyroid hormone - a bone anabolic and catabolic agent.
由: Poole, K, et al.
出版: (2005)

Substrate deprivation therapy reduces brain ganglioside content and GM1 in neonatal storage disease mice
由: Kasperzyk, J, et al.
出版: (2002)

Neuraminidase inhibitors for influenza complications.
由: Del Mar, C, et al.
出版: (2014)

N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis.
由: Kasperzyk, J, et al.
出版: (2004)

Pharmacokinetic Properties of Anti-Influenza Neuraminidase Inhibitors.
由: Chairat, K, et al.
出版: (2012)

Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.
由: Chairat, K, et al.
出版: (2013)

Investigating effects of polyamine catabolism on epidermal differentiation
由: Ling, Blysse
出版: (2019)

Catabolic and anabolic phases of osteodystrophy in aged rats.
由: Roach, H, et al.
出版: (2003)

Neuraminidase inhibitors for preventing and treating influenza in children
由: Wang, K, et al.
出版: (2012)

Neuraminidase inhibitors for preventing and treating influenza in children.
由: Wang, K, et al.
出版: (2012)

TLR9-mediated dendritic cell activation uncovers mammalian ganglioside species with specific ceramide backbones that activate invariant natural killer T cells
由: Paget, C, et al.
出版: (2019)

New GM1 Ganglioside Derivatives for Selective Single and Double Labelling of the Natural Glycosphingolipid Skeleton
由: Polyakova, S, et al.
出版: (2009)

Gangliosides play an important role in the organization of CD82-enriched microdomains.
由: Odintsova, E, et al.
出版: (2006)

Gangliosides play a critical role in the organization of the tetraspanin-enriched microdomains
由: Odintsova, E, et al.
出版: (2005)

Histidine catabolism is a major determinant of methotrexate sensitivity
由: Kanarek, Naama, et al.
出版: (2020)

Dynamic regulation of pectin catabolism in the pathogenicity of Dickeya dadantii
由: Debra Ruth David
出版: (2012)

HYDROCARBON CATABOLISM IN CLADOSPORIUM-RESINAE - EFFECT OF HEXADECANE ON SUCCINATE-DEHYDROGENASE ACTIVITY
由: Turner, A, et al.
出版: (1978)

"Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice" (vol 46, pg 744, 2004)
由: Kasperzyk, J, et al.
出版: (2005)

Neuraminidase inhibitors: the story behind the Cochrane review
由: Doshi, Peter
出版: (2009)

Guidelines on neuraminidase inhibitors in children are not supported by evidence.
由: Symmonds, M, et al.
出版: (2004)

Neuraminidase inhibitors for preventing and treating influenza in children.
由: Matheson, N, et al.
出版: (2003)